Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 22;12(10):1277.
doi: 10.3390/brainsci12101277.

Safety of Clinical Ultrasound Neuromodulation

Sonja Radjenovic  1 , Gregor Dörl  1 , Martin Gaal  1 , Roland Beisteiner  1
Affiliations
Review

Safety of Clinical Ultrasound Neuromodulation

Sonja Radjenovic et al. Brain Sci. .

Abstract

Transcranial ultrasound holds much potential as a safe, non-invasive modality for navigated neuromodulation, with low-intensity focused ultrasound (FUS) and transcranial pulse stimulation (TPS) representing the two main modalities. While neuroscientific and preclinical applications have received much interest, clinical applications are still relatively scarce. For safety considerations, the current literature is largely based on guidelines for ultrasound imaging that uses various physical parameters to describe the ultrasound pulse form and expected bioeffects. However, the safety situation for neuromodulation is inherently different. This article provides an overview of relevant ultrasound parameters with a focus on bioeffects relevant for safe clinical applications. Further, a retrospective analysis of safety data for clinical TPS applications in patients is presented.

Keywords: FUS; TPS; clinical neuromodulation; neuromodulation; transcranial ultrasound.

PubMed Disclaimer

Conflict of interest statement

R.B. receives research grants from STORZ Medical (including equipment) and is President of the Organization for Human Brain Mapping Alpine Chapter and the Austrian Society for fMRI (unpaid). S.R., G.D. and M.G. are involved in TPS research and application projects.

Figures

Figure 1
Figure 1
Experienced pressure and pain were rated during TPS treatment. (A) Percentages over all sessions and (B) number of patients across all sessions.
Figure 2
Figure 2
Adverse events during (A,B) and after (C,D). TPS treatment reported by patients across all sessions and percentage over all sessions, respectively. Detailed numbers are in Table 2.
See this image and copyright information in PMC

References

    1. Darmani G., Bergmann T.O., Butts Pauly K., Caskey C.F., de Lecea L., Fomenko A., Fouragnan E., Legon W., Murphy K.R., Nandi T., et al. Non-Invasive Transcranial Ultrasound Stimulation for Neuromodulation. Clin. Neurophysiol. 2022;135:51–73. doi: 10.1016/j.clinph.2021.12.010. - DOI - PubMed
    1. Meng Y., Hynynen K., Lipsman N. Applications of Focused Ultrasound in the Brain: From Thermoablation to Drug Delivery. Nat. Rev. Neurol. 2021;17:7–22. doi: 10.1038/s41582-020-00418-z. - DOI - PubMed
    1. Sarica C., Nankoo J.-F., Fomenko A., Grippe T.C., Yamamoto K., Samuel N., Milano V., Vetkas A., Darmani G., Cizmeci M.N., et al. Human Studies of Transcranial Ultrasound Neuromodulation: A Systematic Review of Effectiveness and Safety. Brain Stimulat. 2022;15:737–746. doi: 10.1016/j.brs.2022.05.002. - DOI - PubMed
    1. Pereira E.A., Green A.L., Nandi D., Aziz T.Z. Deep Brain Stimulation: Indications and Evidence. Expert Rev. Med. Devices. 2007;4:591–603. doi: 10.1586/17434440.4.5.591. - DOI - PubMed
    1. Alster P., Koziorowski D.M., Za̧bek M., Dzierzȩcki S., Ma̧dry J., Duszyńska-Wa̧s K., Grygarowicz H., Zielonko J., Królicki L., Friedman A. Making a Difference—Positive Effect of Unilateral VIM Gamma Knife Thalamotomy in the Therapy of Tremor in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) Front. Neurol. 2018;9:512. doi: 10.3389/fneur.2018.00512. - DOI - PMC - PubMed

Grants and funding

LinkOut - more resources